Q Pula Trading Management LP Abb Vie Inc. Transaction History

Q Pula Trading Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $337,403 - $386,980	2,514 New	2,514 $337,000
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $387,813 - $493,037	-2,818 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $371,919 - $461,447	2,818 New	2,818 $457,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Q Pula Trading Management LP, based on Form 13F filings with the SEC.

Stay updated on Q Pula Trading Management LP with notifications on news.